Author: Zacks Small Cap Research

1234517230 / 1718 POSTS
By David Bautz, PhD NASDAQ:MNOV READ THE FULL MNOV RESEARCH REPORT Business Update Positive Results for MN-166 (Ibudilast) in COVID-19 Patients at Risk for ARDS On June 8, 2022, MediciNova, Inc. (NASDAQ:MNOV) announced positive topline results for th ...
By Brian Lantier, CFA NYSE:CANG READ THE FULL CANG RESEARCH REPORT Cango Inc. (CANG) reported 1Q22 results that were roughly inline with our expectations. Revenue guidance for 2Q22 and FY2022 was significantly below our expectations due to extended C ...
By John Vandermosten, CFA NASDAQ:TLSA Clinical Results for Second SPMS Patient Tiziana Life Sciences PLC (NASDAQ:TLSA) announced positive clinical results for its second secondary progressive multiple sclerosis (SMPM) patient in a June 8th press rele ...
By M. Marin NTRB:NASDAQ READ THE FULL NTRB RESEARCH REPORT Revenue growth as company moves AVERSA forward… Nutriband Inc. (NTRB:NASDAQ), an emerging a biopharma and medical device company that is developing a portfolio of transdermal pharmaceutical ...
By M. Marin NASDAQ:SQFT READ THE FULL SQFT RESEARCH REPORT MURF IBC could create upside for SQFT Presidio Property Trust’s (NASDAQ:SQFT) sponsored special purpose acquisition company (SPAC), Murphy Canyon Acquisition Corp. (NASDAQ:MURF), is designed ...
By John Vandermosten, CFA NASDAQ:LEXX READ THE FULL LEXX RESEARCH REPORT Lexaria Bioscience Corporation (NASDAQ:LEXX) has announced three material partnerships since the beginning of June that will provide a variety of upfront, milestone and royalty ...
By John Vandermosten, CFA NYSE:CVM READ THE FULL CVM RESEARCH REPORT ASCO Abstract and Poster In late April of this year, CEL-SCI Corporation (NYSE:CVM) emerged from its cocoon and announced that multiple abstracts had been accepted by American Socie ...
By M. Marin NASDAQ:ABVC READ THE FULL ABVC RESEARCH REPORT Lead assets moving forward… ABVC BioPharma (NASDAQ:ABVC) is a biopharma and medical device company developing therapies for a range of conditions focused on oncology/hematology, central nerv ...
By Brad Sorensen, CFA NASDAQ:BBLG READ THE FULL BBLG RESEARCH REPORT Although the stock (NASDAQ:BBLG) of Bone Biologics has suffered along with the rest of the biotech-related space, we remain confident in the company’s technology to improve the bone ...
By M. Marin NASDAQ:EEIQ READ THE FULL EEIQ RESEARCH REPORT Advancing diversification & expansion goals Elite Education Group (NASDAQ:EEIQ) acquired a stake in Davis College, a Toledo, Ohio career training college that offers programs teaching ski ...
1234517230 / 1718 POSTS